IDEAS home Printed from https://ideas.repec.org/a/plo/pone00/0038012.html
   My bibliography  Save this article

Coauthorship and Institutional Collaborations on Cost-Effectiveness Analyses: A Systematic Network Analysis

Author

Listed:
  • Ferrán Catalá-López
  • Adolfo Alonso-Arroyo
  • Rafael Aleixandre-Benavent
  • Manuel Ridao
  • Máxima Bolaños
  • Anna García-Altés
  • Gabriel Sanfélix-Gimeno
  • Salvador Peiró

Abstract

Background: Cost-Effectiveness Analysis (CEA) has been promoted as an important research methodology for determining the efficiency of healthcare technology and guiding medical decision-making. Our aim was to characterize the collaborative patterns of CEA conducted over the past two decades in Spain. Methods and Findings: A systematic analysis was carried out with the information obtained through an updated comprehensive literature review and from reports of health technology assessment agencies. We identified CEAs with outcomes expressed as a time-based summary measure of population health (e.g. quality-adjusted life-years or disability-adjusted life-years), conducted in Spain and published between 1989 and 2011. Networks of coauthorship and institutional collaboration were produced using PAJEK software. One-hundred and thirty-one papers were analyzed, in which 526 authors and 230 institutions participated. The overall signatures per paper index was 5.4. Six major groups (one with 14 members, three with 7 members and two with 6 members) were identified. The most prolific authors were generally affiliated with the private-for-profit sector (e.g. consulting firms and the pharmaceutical industry). The private-for-profit sector mantains profuse collaborative networks including public hospitals and academia. Collaboration within the public sector (e.g. healthcare administration and primary care) was weak and fragmented. Conclusions: This empirical analysis reflects critical practices among collaborative networks that contributed substantially to the production of CEA, raises challenges for redesigning future policies and provides a framework for similar analyses in other regions.

Suggested Citation

  • Ferrán Catalá-López & Adolfo Alonso-Arroyo & Rafael Aleixandre-Benavent & Manuel Ridao & Máxima Bolaños & Anna García-Altés & Gabriel Sanfélix-Gimeno & Salvador Peiró, 2012. "Coauthorship and Institutional Collaborations on Cost-Effectiveness Analyses: A Systematic Network Analysis," PLOS ONE, Public Library of Science, vol. 7(5), pages 1-9, May.
    • Handle: RePEc:plo:pone00:0038012
    DOI: 10.1371/journal.pone.0038012
    as

    Download full text from publisher

    File URL: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0038012
    Download Restriction: no
    File URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0038012&type=printable
    Download Restriction: no
    File URL: https://libkey.io/10.1371/journal.pone.0038012?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Dean T. Jamison & Joel G. Breman & Anthony R. Measham & George Alleyne & Mariam Claeson & David B. Evans & Prabhat Jha & Ann Mills & Philip Musgrove, 2006. "Disease Control Priorities in Developing Countries, Second Edition," World Bank Publications - Books, The World Bank Group, number 7242, December.
    2. Fernando Antoñanzas & Juan Oliva & Mariola Pinillos & Carmelo Juàrez, 2007. "Economic aspects of the new Spanish laws on pharmaceutical preparations," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 8(3), pages 297-300, September.
    3. Peter C Gøtzsche & Jerome P Kassirer & Karen L Woolley & Elizabeth Wager & Adam Jacobs & Art Gertel & Cindy Hamilton, 2009. "What Should Be Done To Tackle Ghostwriting in the Medical Literature?," PLOS Medicine, Public Library of Science, vol. 6(2), pages 1-4, February.
    4. Lisa Bero & Fieke Oostvogel & Peter Bacchetti & Kirby Lee, 2007. "Factors Associated with Findings of Published Trials of Drug–Drug Comparisons: Why Some Statins Appear More Efficacious than Others," PLOS Medicine, Public Library of Science, vol. 4(6), pages 1-10, June.
    5. Reinhardt, Uwe E., 1997. "Making economic evaluations respectable," Social Science & Medicine, Elsevier, vol. 45(4), pages 555-562, August.
    6. Lenard I Lesser & Cara B Ebbeling & Merrill Goozner & David Wypij & David S Ludwig, 2007. "Relationship between Funding Source and Conclusion among Nutrition-Related Scientific Articles," PLOS Medicine, Public Library of Science, vol. 4(1), pages 1-6, January.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Jiming Hu & Yin Zhang, 2017. "Discovering the interdisciplinary nature of Big Data research through social network analysis and visualization," Scientometrics, Springer;Akadémiai Kiadó, vol. 112(1), pages 91-109, July.
    2. Zhao, Yi & Liu, Lifan & Zhang, Chengzhi, 2022. "Is coronavirus-related research becoming more interdisciplinary? A perspective of co-occurrence analysis and diversity measure of scientific articles," Technological Forecasting and Social Change, Elsevier, vol. 175(C).
    3. Ferrán Catalá-López & Gabriel Sanfélix-Gimeno & Manuel Ridao & Salvador Peiró, 2013. "When Are Statins Cost-Effective in Cardiovascular Prevention? A Systematic Review of Sponsorship Bias and Conclusions in Economic Evaluations of Statins," PLOS ONE, Public Library of Science, vol. 8(7), pages 1-1, July.

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Daniel M Cook & Elizabeth A Boyd & Claudia Grossmann & Lisa A Bero, 2007. "Reporting Science and Conflicts of Interest in the Lay Press," PLOS ONE, Public Library of Science, vol. 2(12), pages 1-5, December.
    2. Antoine Popelut & Fabien Valet & Olivier Fromentin & Aurélie Thomas & Philippe Bouchard, 2010. "Relationship between Sponsorship and Failure Rate of Dental Implants: A Systematic Approach," PLOS ONE, Public Library of Science, vol. 5(4), pages 1-9, April.
    3. Lucius Caviola & Nadira Faulmüller & Jim. A. C. Everett & Julian Savulescu & Guy Kahane, 2014. "The evaluability bias in charitable giving: Saving administration costs or saving lives?," Judgment and Decision Making, Society for Judgment and Decision Making, vol. 9(4), pages 303-315, July.
    4. Lisa F. Clark, 2018. "Policy conflicts in global food assistance strategies: balancing local procurement and harmonization," Food Security: The Science, Sociology and Economics of Food Production and Access to Food, Springer;The International Society for Plant Pathology, vol. 10(1), pages 211-222, February.
    5. Gianni Tognoni & Alejandro Macchia, 2020. "Health as a Human Right: A Fake News in a Post-human World?," Development, Palgrave Macmillan;Society for International Deveopment, vol. 63(2), pages 270-276, December.
    6. Joseph H. Cook, 2013. "Principles and standards for benefit–cost analysis of public health preparedness and pandemic mitigation programs," Chapters, in: Scott O. Farrow & Richard Zerbe, Jr. (ed.), Principles and Standards for Benefit–Cost Analysis, chapter 3, pages 110-152, Edward Elgar Publishing.
    7. Feyza G. Sahinyazan & Marie‐Ève Rancourt & Vedat Verter, 2021. "Food Aid Modality Selection Problem," Production and Operations Management, Production and Operations Management Society, vol. 30(4), pages 965-983, April.
    8. Lê, Gillian & Morgan, Rosemary & Bestall, Janine & Featherstone, Imogen & Veale, Thomas & Ensor, Tim, 2016. "Can service integration work for universal health coverage? Evidence from around the globe," Health Policy, Elsevier, vol. 120(4), pages 406-419.
    9. Ivan Moreno-Torres, 2011. "Generic drugs in Spain: price competition vs. moral hazard," Working Papers XREAP2011-04, Xarxa de Referència en Economia Aplicada (XREAP), revised May 2011.
    10. Timotijevic, Lada & Khan, Shumaisa S. & Raats, Monique & Braun, Susanne, 2019. "Research priority setting in food and health domain: European stakeholder beliefs about legitimacy criteria and processes," Food Policy, Elsevier, vol. 83(C), pages 116-124.
    11. United Nations Economic and Social Commission for Asia and the Pacific (ESCAP) South and South-West (ed.), 2012. "Regional Cooperation for Inclusive and Sustainable Development: South and South-West Asia Development Report 2012-2013," SSWA Books and Research Reports, United Nations Economic and Social Commission for Asia and the Pacific (ESCAP) South and South-West Asia Office, number brr4, May.
    12. Johannes Haushofer & Michael Kremer & Ricardo Maertens & Brandon Joel Tan, 2021. "Water Treatment and Child Mortality: Evidence from Kenya," NBER Working Papers 29447, National Bureau of Economic Research, Inc.
    13. Steve Morgan & Morris Barer & Robert Evans, 2000. "Health economists meet the fourth tempter: drug dependency and scientific discourse," Health Economics, John Wiley & Sons, Ltd., vol. 9(8), pages 659-667, December.
    14. Nikaj Silda, 2017. "Peer Effects and Youth Smoking in the European Global Youth Tobacco Survey," Review of Economic Perspectives, Sciendo, vol. 17(3), pages 219-238, September.
    15. Béné, Christophe, 2022. "Why the Great Food Transformation may not happen – A deep-dive into our food systems’ political economy, controversies and politics of evidence," World Development, Elsevier, vol. 154(C).
    16. Hoa‐Thi‐Minh Nguyen & Tom Kompas & Roslyn I. Hickson, 2014. "Aid and the Control of Tuberculosis in Papua New Guinea: Is Australia's Assistance Cost‐Effective?," Asia and the Pacific Policy Studies, Wiley Blackwell, vol. 1(2), pages 364-378, May.
    17. Lessard, Chantale, 2007. "Complexity and reflexivity: Two important issues for economic evaluation in health care," Social Science & Medicine, Elsevier, vol. 64(8), pages 1754-1765, April.
    18. Maynard, Alan & McDaid, David, 2003. "Evaluating health interventions: exploiting the potential," Health Policy, Elsevier, vol. 63(2), pages 215-226, February.
    19. Ivan Moreno-Torres, 2011. "What if there was a stronger pharmaceutical price competition in Spain? When regulation has a similar effect to collusion," Working Papers XREAP2011-02, Xarxa de Referència en Economia Aplicada (XREAP), revised May 2011.
    20. Scott, C. & Hawkins, B. & Knai, C., 2017. "Food and beverage product reformulation as a corporate political strategy," Social Science & Medicine, Elsevier, vol. 172(C), pages 37-45.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:plo:pone00:0038012. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: plosone (email available below). General contact details of provider: https://journals.plos.org/plosone/ .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.